Consumer Genetic Technologies

Ethical and Legal Considerations

I. Glenn Cohen (Harvard Law School, Massachusetts), Nita A. Farahany, Henry T. Greely , Carmel Shachar (Harvard Law School, Massachusetts)

$169.95

Hardback

Not in-store but you can order this
How long will it take?

Availability Information

We source books from suppliers in Australia and overseas. For books we don't currently have in stock, the time it takes to get them from our suppliers can vary widely - from a few days to a few months - so we check each book with each supplier to determine the expected time it will take to be supplied to us.

We then advise you accordingly. If the time taken to get any book is too long for you, you can let us know and we will cancel or adjust your order, and refund as required.

To find out the anticipated arrival time for specific items prior to ordering, please contact us by phone or email:

Phone +61 2 9264 3111, or 1800 4 BOOKS (1800 4 26657) if outside Sydney:
option 1 Abbey's Bookshop (Crime, History, Science, Kids & more) • info@abbeys.com.au
option 2 Language Book Centre (ESL & Foreign Languages) • language@abbeys.com.au
option 3 Galaxy Bookshop (Sci-fi, Fantasy, Romance, Graphic Novels) • sf@galaxybooks.com.au

QTY:

English

Cambridge University Press
16 September 2021

Intellectual property law; Medical & healthcare law; Medical ethics & professional conduct; Medical genetics; Forensic medicine

For the average person, genetic testing has two very different faces. The rise of genetic testing is often promoted as the democratization of genetics by enabling individuals to gain insights into their unique makeup. At the same time, many have raised concerns that genetic testing and sequencing reveal intensely personal and private information. As these technologies become increasingly available as consumer products, the ethical, legal, and regulatory challenges presented by genomics are ever looming. Assembling multidisciplinary experts, this volume evaluates the different models used to deliver consumer genetics and considers a number of key questions: How should we mediate privacy and other ethical concerns around genetic databases? Does aggregating data from genetic testing turn people into products by commercializing their data? How might this data reduce or exacerbate existing healthcare disparities? Contributing authors also provide guidance on protecting consumer privacy and safety while promoting innovation.

Edited by: I. Glenn Cohen (Harvard Law School Massachusetts), Nita A. Farahany, Henry T. Greely, Carmel Shachar (Harvard Law School, Massachusetts)
Imprint: Cambridge University Press
Country of Publication: United Kingdom
Dimensions: Height: 235mm, Width: 159mm, Spine: 22mm
Weight: 590g
ISBN: 9781108836616
ISBN 10: 1108836615
Pages: 380
Publication Date: 16 September 2021
Audience: Professional and scholarly , Undergraduate
Format: Hardback
Publisher's Status: Active

I. Glenn Cohen is the James A. Attwood and Leslie Williams Professor of Law at Harvard Law School. He is one of the world's leading experts on the intersection of bioethics and the law, as well as health law. He is the author of more than 150 articles in venues like the New England Journal of Medicine, JAMA, Science and the Harvard Law Review, and the author, editor, or co-editor of 15 books. He has appeared on or been covered by media outlets such as PBS, NPR, ABC, CNN, MSNBC, the New York Times, and the Boston Globe. Professor Cohen has also been a Radcliffe Institute and Hastings Center Fellow. Nita A. Farahany is Distinguished Professor of Law and Philosophy at Duke University. She is a widely published scholar on the ethical, legal, and social implications of the biosciences and emerging technologies, and a frequent commentator at international conferences including the Aspen Ideas Festival, TED, and the World Economic Forum. Henry T. Greely is the Deane F. and Kate Edelman Johnson Professor of Law at Stanford University where he specializes in ethical, legal, and social issues arising from the biosciences. He is the author of The End of Sex and the Future of Human Reproduction (2016) and CRISPR People: The Science and Ethics of Editing Humans (2021). Carmel Shachar is the Executive Director of the Petrie-Flom Center at Harvard Law School. Her work focuses on access to care and digital health. She is the co-editor of several other volumes including Transparency in Health Care and Disability, Law, Health, and Bioethics.

Reviews for Consumer Genetic Technologies: Ethical and Legal Considerations

'This book provides essential reading for anyone interested in what is currently possible or what might soon become possible and how society should think about governing the responsible use of genetic data and biotechnologies … Highly recommended.' D. Schulman, Choice Magazine